Financials
- Market Capitalization 2.07 B
- Employee 398
- Founded 1989
- CEO Nick Colangelo
- Website www.vcel.com
- Headquarter Michigan, United States
- FIGI BBG000BDCM24
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
112.53
Fiyat/satışlar oranı
6.8
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1909 | NVAX Novavax, Inc. - Common Stock | 12.71 USD | +0.39% | +16.39% | +34.93% | +46.77% | 2.10 B USD | ||
| 1914 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 8.18 USD | -2.15% | +2.00% | +0.12% | +24.32% | 2.09 B USD | ||
| 1925 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.85 USD | -3.99% | -15.38% | +20.31% | -27.50% | 2.06 B USD | ||
| 1930 | VRDN Viridian Therapeutics, Inc. - Common Stock | 18.11 USD | -1.04% | -0.71% | -15.65% | -19.33% | 2.05 B USD |